Cargando…
Complement activation in patients with COVID-19: A novel therapeutic target
Autores principales: | Cugno, Massimo, Meroni, Pier Luigi, Gualtierotti, Roberta, Griffini, Samantha, Grovetti, Elena, Torri, Adriana, Panigada, Mauro, Aliberti, Stefano, Blasi, Francesco, Tedesco, Francesco, Peyvandi, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224678/ https://www.ncbi.nlm.nih.gov/pubmed/32417135 http://dx.doi.org/10.1016/j.jaci.2020.05.006 |
Ejemplares similares
-
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients
por: Cugno, Massimo, et al.
Publicado: (2022) -
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
por: Cugno, Massimo, et al.
Publicado: (2021) -
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
por: Gualtierotti, Roberta, et al.
Publicado: (2019) -
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19
por: Valenti, Luca, et al.
Publicado: (2021) -
Corrigendum to “Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19” [J. Autoimmun. 117C (2020) 102595]
por: Valenti, Luca, et al.
Publicado: (2021)